Скачать или смотреть Trump Administration Says Medicare Will Save $12 Billion From New Drug Price Negotiations

The Trump administration says Medicare will save about $12 billion — a 44% reduction — on 15 high-cost drugs after the latest round of price negotiations. The cuts include major GLP-1 medications like Ozempic and Wegovy, as well as cancer, asthma, and diabetes treatments used by 5.3 million Medicare enrollees. Patients are expected to save $685 million out of pocket starting in 2027. At the same time, Trump is pushing voluntary “most favored nation” pricing deals, with Novo Nordisk agreeing to sell key GLP-1 drugs to Medicare for $245, expanding coverage for obesity and diabetes medications. Industry groups continue to warn of possible coverage impacts, but experts call the second-round results “successful.”

#MedicareSavings #DrugPriceNegotiation #TrumpAdministration #Ozempic #Wegovy #PrescriptionDrugs #Medicare2027 #HealthcareCosts #GLP1Drugs #NovoNordisk #MostFavoredNationPricing #MedicareEnrollees